CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56 | +21.7% | 2,074 | -0.7% | 0.00% | – |
| Q2 2023 | $46 | 0.0% | 2,088 | -2.2% | 0.00% | – |
| Q1 2023 | $46 | +411.1% | 2,134 | +392.8% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 433 | -23.0% | 0.00% | – |
| Q3 2022 | $14,000 | +366.7% | 562 | +295.8% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 142 | -10.7% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 159 | -29.3% | 0.00% | – |
| Q4 2021 | $4,000 | +300.0% | 225 | +508.1% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |